Atara reports patient death in cancer treatment study
Atara Biotherapeutics, a South San Francisco-based drug development company with major operations in Thousand Oaks, reported to the U.S. Food and Drug Administration on Feb. 18 that a patient died in one of its Phase 1 trials. The patient, who was being treated at a Memorial Sloan Kettering Cancer Center location in New York, suffered Read More →
St. John’s in Oxnard teams with Morehouse medical school to improve care, diversity
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Changing of the guard at VNA Health
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
With mask mandates lifted and cases dropping, region ponders pandemic’s next phase
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Interim St. John’s leader named permanent CEO
About five months after the top executive of the St. John’s hospitals in Oxnard and Camarillo resigned, their owner, Dignity Health, has announced a familiar face as their new leader. Barry Wolfman, who brings more than 30 years of hospital operations and health care management experience, has been appointed president and CEO of Dignity Health’s Read More →
LTC reports dip in Q4 earnings
Westlake Village-based real estate investment trust LTC Properties on Feb. 17 reported a 27% year-to-year decline in fourth quarter net income for 2021, in financial results released after the market closed on Feb. 17. The company’s net income was $12.7 million, or 32 cents per diluted share, in the fourth quarter of 2021, down from Read More →
Amgen shares jump after company announces buyback plan and long-term projections
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
